Tenaya Therapeutics, Inc.
Tenaya Therapeutics, Inc.
TNYA
Valuace
70
Růst
45
Zdraví
75
Cena
$ 1.30
Dnes
--0.01 (-1.61%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.2B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-114%
ROA
-90%
PE
-1
PS
0
Cena 1R
0-2
⌀ Cena
0.95
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
09-03-2026
Poslední dividenda

Profil

Tenaya Therapeutics, Inc., biotechnologická společnost, objevuje, vyvíjí a dodává terapie srdečních onemocnění ve Spojených státech. Vyvíjí své produkty prostřednictvím buněčné regenerace, genové terapie a platforem přesné medicíny. Společnost vyvíjí TN-201, genovou terapii na bázi adeno-asociovaného viru (AAV) k řešení genetické hypertrofické kardiomyopatie (gHCM) způsobené haplonedostatečnými mutacemi genu proteinu C3 (MYBPC3) vážícího myosin; a TN-301, malý inhibitor molekuly histondeacetylázy 6 (HDAC6i) pro použití při srdečním selhání se zachovanou ejekční frakcí (HFpEF) a genetickou dilatovanou kardiomyopatií (gDCM). Vyvíjí také TN-401, genovou terapii založenou na AAV, která se zabývá genetickou arytmogenní pravokomorovou kardiomyopatií (gARVC) způsobenou genovými mutacemi plakophilinu 2 (PKP2); genovou terapii založenou na AAV, která má dodat gen DWORF (trpaslík open reading frame) v srdci pro DCM; a program Reprogramování, AAV-založený na regeneraci srdce, který má nahradit srdeční buňky ztracené u pacientů se srdečním selháním v důsledku předchozího infarktu myokardu. Společnost byla založena v roce 2016 a sídlí v jižním San Francisku v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
97
Založení
2021-07-30
Adresa
171 Oyster Point Boulevard
CEO
Faraz Ali

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019
Total Revenues0.000.000.000.000.000.000.000.00
Cost of Revenues0.008,436.008,468.008,687.000.000.000.000.00
Gross Profit0.00-8,436.00-8,468.00-8,687.000.000.000.000.00
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues0.000.000.000.000.000.000.000.0017,664.000.00
Cost of Revenues-3,948.001,864.002,084.000.000.000.002,123.002,155.002,987.002,977.00
Gross Profit3,948.00-1,864.00-2,084.000.000.000.00-2,123.00-2,155.0014,677.00-2,977.00
Operating Income TTM 2025202420232022202120202019
R&D Expenses0.000.000.0098,038.0094,537.0054,393.0031,099.0023,148.00
Selling General & Admin Expenses0.000.000.0033,155.0031,084.0018,413.007,813.004,564.00
Depreciation & Amortization8,436.008,436.008,468.008,687.006,467.002,961.002,483.001,989.00
Total Operating Expenses93,331.0084,895.00107,480.00131,193.00125,621.0072,806.0038,912.0027,712.00
Operating Income-93,331.00-93,331.00-115,948.00-131,193.00-125,621.00-72,806.00-38,912.00-27,712.00
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.000.000.000.000.000.000.000.0022,865.0023,091.00
Selling General & Admin Expenses0.000.000.000.000.000.000.000.005,594.004,852.00
Depreciation & Amortization1,827.001,864.002,084.002,661.002,089.002,101.002,123.002,155.002,987.002,977.00
Total Operating Expenses24,723.0019,072.0021,998.0027,538.0024,652.0026,711.0028,700.0031,607.0028,459.0027,943.00
Operating Income-20,775.00-20,936.00-24,082.00-27,538.00-24,652.00-26,711.00-30,823.00-33,762.00-31,446.00-30,920.00
Net Income TTM 2025202420232022202120202019
Interest Income2,682.002,682.004,737.007,056.001,954.00108.0087.00453.00
Interest Expense0.000.000.000.00-1.960.000.000.00
Other Expense2,734.002,734.004,819.007,109.001,956.0085.00517.001,481.00
IBT-90,597.00-90,597.00-111,129.00-124,084.00-123,665.00-72,721.00-38,395.00-26,231.00
Income Tax Expense0.000.000.000.00-1.96-3,069.00-87.00-453.00
Net Income-90,597.00-90,597.00-111,129.00-124,084.00-123,663.04-69,652.00-38,308.00-25,778.00
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income574.00658.00815.00635.00812.001,080.001,393.001,452.001,470.001,776.00
Interest Expense0.000.000.000.000.000.000.000.000.000.00
Other Expense600.00661.00799.00674.00816.001,077.001,392.001,534.001,511.001,777.00
IBT-20,175.00-20,275.00-23,283.00-26,864.00-23,836.00-25,634.00-29,431.00-32,228.00-29,935.00-29,143.00
Income Tax Expense0.000.000.000.000.000.000.000.002,943.193,016.59
Net Income-20,175.00-20,275.00-23,283.00-26,864.00-23,836.00-25,634.00-29,431.00-32,228.00-29,935.00-29,143.00
Per Share Data TTM 2025202420232022202120202019
EPS$0.00$0.00$0.00$-1.68$-2.76$-3.93$-1.41$-0.95
EPS Diluted$0.00$0.00$0.00$-1.68$-2.76$-3.93$-1.41$-0.95
Shares Outstanding152,971.26152,971.2684,822.0073,786.1344,823.6017,734.1727,200.0827,074.37
Diluted Shares Outstanding152,971.26152,971.2684,822.0073,786.1344,823.6017,734.1727,200.0827,074.37
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.44$-0.39
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.44$-0.39
Shares Outstanding152,971.26163,345.97162,791.58109,869.2886,406.0786,162.8485,706.5080,982.3368,330.3473,924.94
Diluted Shares Outstanding152,971.26163,345.97162,791.58109,869.2886,406.0786,162.8485,706.5080,982.3368,330.3473,924.94
Current Assets TTM 202420232022202120202019
Cash And Equivalents58,134.004,323.0045,681.0095,272.0038,129.00128,535.0023,872.00
Short Term Investments41,169.0057,123.0058,961.0091,255.00213,171.000.002,753.00
Total Cash & ST Investments99,303.0061,446.00104,642.00204,230.00251,300.00128,535.0026,625.00
Accounts Receivable0.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets5,726.005,929.006,940.007,227.004,058.000.000.00
Total Current Assets105,029.0067,375.00111,582.00193,754.00255,358.00129,964.0027,742.00
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents56,312.0062,671.0053,772.004,323.008,231.0058,134.0059,303.0045,681.0082,153.0075,565.00
Short Term Investments0.008,996.0034,386.0057,123.0071,238.0041,169.0062,946.0058,961.0039,600.0056,940.00
Total Cash & ST Investments56,312.0071,667.0088,158.0061,446.0079,469.0099,303.00122,249.00104,642.00121,753.00132,505.00
Accounts Receivable0.000.000.000.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.000.000.000.00
Other Current Assets4,927.004,208.006,327.005,929.005,861.005,726.006,450.006,940.005,075.006,401.00
Total Current Assets61,239.0075,875.0094,485.0067,375.0085,330.00105,029.00128,699.00111,582.00126,828.00138,906.00
Long-Term Assets TTM 202420232022202120202019
Net Property, Plant & Equipment53,093.0047,748.0053,256.0062,695.0054,705.0017,185.009,575.00
Goodwill0.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.00
Long-Term Investments419.000.000.0017,703.000.000.000.00
Other Long-Term Assets4,644.004,817.005,677.004,793.004,126.001,012.00684.00
Total Long-Term Assets58,156.0052,565.0058,933.0085,191.0058,831.0018,197.0010,259.00
Total Assets163,185.00119,940.00170,515.00278,945.00314,189.00148,161.0038,001.00
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment39,497.0041,967.0044,654.0047,748.0050,379.0053,093.0050,573.0053,256.0054,468.0057,172.00
Goodwill0.000.000.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.000.000.000.00
Long-Term Investments0.000.000.000.000.00419.00682.00682.006,367.0019,136.00
Other Long-Term Assets4,244.004,309.004,813.004,817.004,873.004,644.004,945.004,995.005,734.005,540.00
Total Long-Term Assets43,741.0046,276.0049,467.0052,565.0055,252.0058,156.0056,200.0058,933.0066,569.0081,848.00
Total Assets104,980.00122,151.00143,952.00119,940.00140,582.00163,185.00184,899.00170,515.00193,397.00220,754.00
Current Liabilities TTM 202420232022202120202019
Accounts Payable4,319.005,162.005,630.009,578.0010,721.001,017.00600.00
Short-Term Debt3,363.002,778.008,638.004,006.001,994.000.000.00
Other Current Liabilities8,194.007,687.008,465.0010,664.00162.004,024.003,520.00
Current Liabilities16,712.0015,975.0022,733.0024,248.0021,774.005,041.004,120.00
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable2,843.003,297.005,064.005,162.005,839.004,319.006,659.005,630.005,902.008,484.00
Short-Term Debt2,926.002,834.002,794.002,778.003,011.003,363.004,064.008,638.006,308.006,894.00
Other Current Liabilities7,441.006,008.005,872.007,687.007,125.008,194.008,435.008,465.007,167.005,539.00
Current Liabilities13,210.0012,654.0014,152.0015,975.0016,177.0016,712.0019,158.0022,733.0019,377.0020,917.00
Long-Term Liabilities TTM 202420232022202120202019
Long-Term Debt12,210.0010,830.008,105.0011,093.0013,707.000.000.00
Capital Leases12,210.0013,608.0012,424.0015,099.0013,707.000.000.00
Def. Tax Liability0.000.000.000.000.000.000.00
Total Liabilities29,188.0027,086.0031,091.00278,945.0035,663.00229,476.0081,740.00
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt8,601.009,376.0010,117.0010,830.0011,527.0012,210.007,302.008,105.008,890.009,657.00
Capital Leases11,527.0012,210.0012,911.0013,608.0014,538.0012,210.007,302.008,105.0012,044.0013,104.00
Def. Tax Liability0.000.000.000.000.000.000.000.000.000.00
Total Liabilities22,112.0022,323.0024,556.0027,086.0027,980.0029,188.0026,719.0031,091.0028,513.0030,814.00
Total Common Equity TTM 202420232022202120202019
Common Stock8.008.007.007.004.000.000.00
Retained Earnings-464,941.00-514,411.00-403,282.00-279,198.00-155,533.00-82,812.00-44,417.00
Comprehensive Income-67.0028.00-106.00-378.00-141.000.000.00
Total Common Equity133,997.0092,854.00139,424.00243,376.00278,526.00-81,315.00-43,739.00
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock16.0016.0016.008.008.008.008.007.007.007.00
Retained Earnings-584,833.00-564,558.00-541,275.00-514,411.00-490,575.00-464,941.00-435,510.00-403,282.00-373,347.00-344,204.00
Comprehensive Income0.00-1.00-10.0028.0076.00-67.00-120.00-106.00-261.00-333.00
Total Common Equity82,868.0099,828.00119,396.0092,854.00112,602.00133,997.00158,180.00139,424.00164,884.00189,940.00
Other TTM 202420232022202120202019
Total Debt15,573.0013,608.0012,424.0015,099.0013,707.000.000.00
Book Value133,997.0092,854.00139,424.000.00278,526.00-81,315.00-43,739.00
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.000.000.000.000.000.000.000.000.000.00
Book Value82,868.0099,828.00119,396.0092,854.00112,602.00133,997.00158,180.00139,424.00164,884.00189,940.00
Cash Flow From Operating Activities TTM 2025202420232022202120202019
Net Income-120,737.00-90,597.00-111,129.00-124,084.00-123,665.00-72,721.00-38,395.00-26,231.00
Depreciation & Amortization9,446.008,847.008,468.008,687.006,467.002,961.002,483.001,989.00
Stock-Based Compensation16,799.0013,046.0016,501.0015,309.0011,467.002,950.00741.00414.00
Change Working Capital-7,473.00-2,456.00-7,931.00-5,648.00-849.004,742.00-234.00-250.00
Change In Accounts Receivable0.000.000.000.000.000.000.000.00
Change In Accounts Payable-4,219.00-1,430.00-581.00-3,282.001,660.008,600.00142.00397.00
Change In Inventories0.000.000.000.000.000.000.000.00
Other Non-cash Items33,220.002,896.003,590.003,664.002,156.001,064.00-75.0064.00
Cash from Operations-97,839.000.000.00-102,072.00-104,424.00-60,812.00-35,447.00-24,096.00
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-20,175.00-20,275.00-23,283.00-26,864.00-23,836.00-25,634.00-29,431.00-32,228.00-29,935.00-29,143.00
Depreciation & Amortization1,796.001,864.002,384.002,661.002,089.002,101.002,123.002,155.002,987.002,181.00
Stock-Based Compensation2,745.002,934.003,636.003,731.003,759.000.004,611.004,224.003,949.004,015.00
Change Working Capital893.00-921.001,007.00-3,435.00-1,036.00-1,317.00-1,939.00-3,639.00-671.00-1,224.00
Change In Accounts Receivable0.000.000.000.000.000.000.000.000.000.00
Change In Accounts Payable531.00-447.00-1,135.00-379.00-701.001,280.00-2,432.001,272.00-305.00-2,754.00
Change In Inventories0.000.000.000.000.000.000.000.000.000.00
Other Non-cash Items801.00799.00643.00795.00636.005,014.001,019.00828.0011,974.00848.00
Cash from Operations0.000.000.000.000.000.000.000.00-21,924.00-23,638.00
Cash Flow From Investing Activities TTM 2025202420232022202120202019
Capital Expenditure-1,039.00-618.00-1,025.00-1,239.00-20,630.00-25,121.00-9,763.00-2,926.00
Acquisitions0.000.000.000.000.000.000.000.00
Investments-50,097.000.00-87,069.00-56,644.00-140,476.00-213,443.000.00-12,657.00
Sales of Investment83,848.0056,701.0089,208.00106,623.00244,750.000.002,753.0010,000.00
Other Investing Activities-17.000.000.00-25.008.000.000.000.00
Cash from Investing32,695.000.000.0048,715.0083,652.00-238,564.00-7,010.00-5,583.00
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-67.00-26.00-142.00-383.00-204.00-184.00-73.00-564.00-394.00-8.00
Acquisitions0.000.000.000.000.000.000.000.000.000.00
Investments0.000.000.000.00-2,011.00-50,607.00-10,808.00-23,643.00-15,646.000.00
Sales of Investment0.008,886.0025,130.0022,685.0016,318.0020,681.0032,492.0019,717.001,139.0030,500.00
Other Investing Activities0.000.000.000.000.000.000.000.00-18.00-4.00
Cash from Investing0.000.000.000.000.000.000.000.00-14,919.0030,488.00
Cash Flow From Financing Activities TTM 2025202420232022202120202019
Debt Repaid0.000.000.000.000.000.000.000.00
Debt Issued2,469.0013,608.001,184.00-2,675.001,392.0013,707.000.000.00
Issuance of Common Stock47,712.000.000.003,868.0077,387.00188,541.000.000.00
Repurchase of Common Stock0.000.000.000.000.00-13.00-1.00-3.00
Dividends Paid0.000.000.000.000.000.000.000.00
Other Financing Activities9.370.000.00181.00380.0020,442.00147,269.0030,514.00
Cash from Financing47,712.000.000.004,049.0077,767.00208,970.00147,268.0030,511.00
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.000.000.000.000.000.000.000.000.000.00
Debt Issued11,527.00-683.00-701.00-697.00-930.00-1,035.004,207.00-1,058.00380.00-1,060.00
Issuance of Common Stock0.000.000.000.000.000.000.000.00371.000.00
Repurchase of Common Stock0.000.000.000.000.000.000.000.000.000.00
Dividends Paid0.000.000.000.000.000.000.000.000.000.00
Other Financing Activities0.000.000.000.000.000.000.000.00371.000.00
Cash from Financing0.000.000.000.000.000.000.000.00371.000.00
Cash position TTM 2025202420232022202120202019
Net Change in Cash-17,169.0096,224.00-41,621.00-49,308.0056,995.00-90,406.00104,811.00832.00
Closing Cash Balance58,134.00100,966.004,742.0046,363.0095,671.0038,676.00129,082.0024,271.00
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash44,235.00-6,359.008,899.0049,449.00-3,908.00-49,903.00-1,432.0013,622.00-36,472.006,850.00
Closing Cash Balance100,966.0056,312.0063,090.0054,191.004,742.008,231.0058,553.0059,985.0045,681.0082,835.00
Free Cash Flow TTM 2025202420232022202120202019
Free Cash Flow-98,878.00-68,882.00-91,526.00-103,311.00-125,054.00-85,933.00-45,210.00-27,022.00
Real Free Cash Flow-115,677.00-81,928.00-108,027.00-118,620.00-136,521.00-88,883.00-45,951.00-27,436.00
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-14,007.00-15,625.00-15,755.00-23,495.00-18,592.00-20,020.00-23,690.00-29,224.00-22,318.00-23,646.00
Real Free Cash Flow-16,752.00-18,559.00-19,391.00-27,226.00-22,351.00-20,020.00-28,301.00-33,448.00-26,267.00-27,661.00
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-1.3-3.3-1.4
P/S02.99.4
P/B1.40.95.2
P/FCF-1.4-2.9-1.5
Market cap$0.2$1.3
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets11 %6 %0 %
Debt to Income-12.7 %-12.5 %0 %
Debt to Free cash flow-14.1 %-640.3 %0 %
Interest expense percentage0 %5.2 %44.7 %
Current ratio4.6 8.7 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-109.3 %-43.7 %0 %
ROA-86.3 %-45.7 %0 %
CapEx to Revenue0 %1.2 %0 %
RaD to Revenue0 %97.8 %0 %
ROEM0.0 14012.5

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin0 %7.8 %68.7 %
Operating margin0 %-131.8 %35.5 %
Net margin0 %-125.2 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding163.3 mil 63.6 mil
Employee count0.1 tis 0.1 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader